Ephedra Imports Legal While Nutraceutical Appeal Underway – Emord
This article was originally published in The Tan Sheet
FDA's refusal to allow Hong Kong-based broker EMAX to import ephedra-containing dietary supplements into the U.S. violates an April 2005 court ruling which invalidated the agency's ban on the botanical, according to a lawsuit filed April 21 by the firm Emord & Associates
You may also be interested in...
FDA lawyers misrepresented product labeling for Nutraceutical Corporation's ephedra dietary supplements to a Utah appeals court by referencing a discontinued label that instructed consumers to take high doses of the product, according to law firm Emord & Associates
FDA needs to "act promptly to address issues raised" by the recent Utah federal court decision that challenged aspects of the agency's ban on ephedra, leading supplement trade groups state in a joint letter to the agency
A Utah federal court has barred FDA from enforcing its ban on ephedra products containing 10 mg or less of ephedrine alkaloids per daily dose